Roberto A. Mignone's most recent trade in Guardant Health Inc was a trade of 6,833 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | Roberto A. Mignone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 6,833 | 6,833 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Roberto A. Mignone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 4,203 | 4,203 | - | - | Restricted Stock Units | |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 14,492 | 14,492 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 9,632 | 105,315 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 9,632 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | A. Roberto Mignone | Director | Sale of securities on an exchange or to another person at price $ 22.01 per share. | 20 Dec 2024 | 286,000 | 695,000 (0%) | 0% | 22.0 | 6,294,031 | Ordinary Shares |
| Guardant Health Inc | Roberto A. Mignone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 19,535 | 19,535 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Roberto A. Mignone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 12,671 | 12,671 | - | - | Restricted Stock Units | |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 18 Jun 2024 | 519,000 | 981,000 (0%) | 0% | 17.0 | 8,838,570 | Ordinary Shares |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 0 | - | - | Restricted Share Units | |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 1,595,683 (0%) | 0% | - | Ordinary Shares | |
| Teva- Pharmaceutical Indus... | Roberto A. Mignone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 9,632 | 9,632 | - | - | Restricted Share Units |